Proceedings: Using Stem Cell Therapies to Reestablish Osteogenic Capability for Bone Regeneration

  • Littman N
  • Abo A
5Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Summary The California Institute for Regenerative Medicine (CIRM) has invested approximately $70 million in programs targeting various orthopedic indications, including osteoporosis, bone fracture healing, vertebral compression fractures, and several others. The present article serves to outline the current state of CIRM’s more advanced programs, comparing and contrasting them with the current standard of care and several other novel approaches under development. - See more at: http://www.stemcellsportal.com/content/2015-0202#sthash.Zek9KMW5.XyVokFbX.dpuf

Cite

CITATION STYLE

APA

Littman, N., & Abo, A. (2015). Proceedings: Using Stem Cell Therapies to Reestablish Osteogenic Capability for Bone Regeneration. Stem Cells Translational Medicine, 4(11), 1247–1250. https://doi.org/10.5966/sctm.2015-0202

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free